| Company/Division name | Panacea Medical Technologies U.S. |
| Parent company | Panacea Medical Technologies |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 65 |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2021 |
| Capital investment ($): | 11.7 |
| Country(ies) from which reshored: | India |
| City reshored to: | Noblesville |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | radiation therapy machines for cancer treatment |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customer responsiveness improvement, Government Incentives, Proximity to customers/market, Skilled workforce availability/training |
